[{"Assets_0_Q3_USD":76381000.0,"CommonStockSharesOutstanding_0_Q3_shares":27140484.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-37885000.0,"NetIncomeLoss_1_Q3_USD":-12829000.0,"NetIncomeLoss_3_Q3_USD":-42047000.0,"StockholdersEquity_0_Q3_USD":44043000.0,"Ticker":"SNDX","CIK":"1395937","name":"SYNDAX PHARMACEUTICALS INC","OfficialName":"Syndax Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"934158860.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191107"}]